Bioactive cembranoids from the soft coral Sinularia crassa.

Area of Science:

• Marine Natural Products Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Soft corals, particularly from the genus Sinularia, are prolific sources of structurally diverse secondary metabolites.
• Cembranoids are a class of diterpenes commonly found in marine organisms, often exhibiting interesting biological activities.
• The exploration of Formosan soft corals continues to yield novel chemical entities.

Purpose of the Study:

• To isolate and characterize new cembranoid compounds from the Formosan soft coral Sinularia crassa.
• To investigate the chemical structures and absolute configurations of the isolated compounds.
• To evaluate the anti-inflammatory and cytotoxic effects of the novel cembranoids.

Main Methods:

• Chemical isolation techniques including chromatography.
• Spectroscopic analysis (NMR, MS) for structure elucidation.
• Mosher's method for determining absolute configuration.
• In vitro assays to assess protein inhibition and cytotoxicity.

Main Results:

• Eight new cembranoids, designated crassarines A-H (1-8), were successfully isolated.
• Compounds 1-3 feature a rare 1,12-oxa-bridged tetrahydrofuran ring system.
• Compounds 4 and 5 are novel 1,11-oxa-bridged tetrahydropyranocembranoids.
• The absolute configuration of compound 6 was determined.
• Compounds 6 and 8 significantly inhibited inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein expression, respectively.
• Compounds 4-8 exhibited no cytotoxicity against tested human liver cancer cell lines.

Conclusions:

• The study successfully identified eight new cembranoids from Sinularia crassa, expanding the known diversity of this chemical class.
• The novel structural motifs found in compounds 1-5 highlight unique biosynthetic pathways in soft corals.
• Compounds 6 and 8 demonstrate potential as anti-inflammatory agents by inhibiting key pro-inflammatory mediators.
• The non-cytotoxic nature of compounds 4-8 suggests potential for further investigation in therapeutic applications.